OLEARY PATRICK J sold (to issuer) $1.4M of AVNS
OLEARY PATRICK J sold (to issuer) 54,640 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($1.37M total) on 2026-07-27.
How this was made
The 30-second read
Why it matters
The disclosed fact is the size, price, and structure of the director’s sale to the issuer; it does not include guidance, earnings, litigation, or product/regulatory updates.
Market read
Traders may note the insider sale size, but the sale-to-issuer coding and lack of fundamental updates make it unlikely to drive a durable repricing.
What to watch
The filing does not state whether the sale was part of a 10b5-1 plan (it says no), but it also provides no rationale or linkage to fundamentals, limiting interpretability.
Background
The article is a primary-source SEC Form 4 disclosure for an insider transaction by a director of Avanos Medical, Inc.
Ticker impact
Avanos Medical director Patrick J. O’Leary sold 54,640 shares to the issuer at $25.00/share, totaling about $1.37M, per Form 4.
Low near-term impact; any effect is likely absorbed as routine buyback-related mechanics.
The filing is a Form 4 insider transaction with no new operating, regulatory, or financial datapoints; it specifies sale to issuer and post-transaction holdings of 0 shares.
Market effects
No sector read-across; this is company-specific insider transaction reporting.
None indicated.
None indicated.
Counterpoint
Because the transaction is coded as a sale to the issuer, it may reflect planned buyback participation rather than bearish information.
Key entities
- issuerAVANOS MEDICAL, INC.
Company whose director insider transaction is disclosed on Form 4.
- insiderOLEARY PATRICK J
Director who sold 54,640 shares to the issuer at $25.00/share.
